Three-dimensional ultrasound fusion imaging in precise needle placement for thermal ablation of hepatocellular carcinoma

References

• Liver EAftSot. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):1–9. doi: 10.1016/j.jhep.2018.03.019.
   Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68(2):723–750. doi: 10.1002/hep.29913.
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi: 10.1016/j.jhep.2021.11.018.
   PubMed Web of Science ®Google Scholar
• Solomon SB, Silverman SG. Imaging in interventional oncology. Radiology. 2010;257(3):624–640. doi: 10.1148/radiol.10081490.
   PubMed Web of Science ®Google Scholar
• Kessner R, Nakamoto DA, Kondray V, et al. Contrast-Enhanced ultrasound guidance for interventional procedures. J Ultrasound Med. 2019;38(10):2541–2557. doi: 10.1002/jum.14955.
   PubMed Web of Science ®Google Scholar
• Rose SC, Hassanein TI, Easter DW, et al. Value of three-dimensional US for optimizing guidance for ablating focal liver tumors. J Vasc Interv Radiol. 2001;12(4):507–515. doi: 10.1016/s1051-0443(07)61892-2.
   PubMed Web of Science ®Google Scholar
• Xu HX, Yin XY, Lu MD, et al. Usefulness of three-dimensional sonography in procedures of ablation for liver cancers: initial experience. J Ultrasound Med. 2003;22(11):1239–1247. doi: 10.7863/jum.2003.22.11.1239.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol. 2007;188(2):480–488. doi: 10.2214/AJR.05.2079.
   PubMed Web of Science ®Google Scholar
• Lee MW, Rhim H, Cha DI, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol. 2012;198(6):1438–1444. doi: 10.2214/AJR.11.7568.
   PubMed Web of Science ®Google Scholar
• Makino Y, Imai Y, Igura T, et al. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma. Dig Dis. 2013;31(5-6):485–489. doi: 10.1159/000355257.
   PubMed Web of Science ®Google Scholar
• Ye J, Huang G, Zhang X, et al. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report. Int J Hyperthermia. 2019;36(1):55–64. doi: 10.1080/02656736.2018.1530460.
   PubMed Web of Science ®Google Scholar
• Minami Y, Minami T, Hagiwara S, et al. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma. Eur Radiol. 2018;28(5):1986–1993. doi: 10.1007/s00330-017-5162-8.
   PubMed Web of Science ®Google Scholar
• Minami Y, Minami T, Takita M, et al. Radiofrequency ablation for hepatocellular carcinoma: clinical value of ultrasound-ultrasound overlay fusion for optimal ablation and local controllability. Hepatol Res. 2020;50(1):67–74. doi: 10.1111/hepr.13407.
   PubMed Web of Science ®Google Scholar
• Xu EJ, Lv SM, Li K, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperthermia. 2018;34(6):870–876. doi: 10.1080/02656736.2017.1373306.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Lee JM, Lee DH, et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66(2):347–354. doi: 10.1016/j.jhep.2016.09.003.
   PubMed Web of Science ®Google Scholar
• Casadaban LC, Catalano PJ, Lee LK, et al. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study. Eur J Nucl Med Mol Imaging. 2021;48(9):2914–2924. doi: 10.1007/s00259-021-05206-5.
   PubMed Web of Science ®Google Scholar
• Shyn PB, Casadaban LC, Sainani NI, et al. Intraprocedural ablation margin assessment by using ammonia perfusion PET during FDG PET/CT-guided liver tumor ablation: a pilot study. Radiology. 2018;288(1):138–145. doi: 10.1148/radiol.2018172108.
   PubMed Web of Science ®Google Scholar
• Xing S, Romero JC, Cool DW, et al. 3D US-based evaluation and optimization of tumor coverage for US-guided percutaneous liver thermal ablation. IEEE Trans Med Imaging. 2022;41(11):3344–3356. doi: 10.1109/TMI.2022.3184334.
   PubMed Web of Science ®Google Scholar
• Xu E, Long Y, Li K, et al. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. Int J Hyperthermia. 2019;35(1):159–167. doi: 10.1080/02656736.2018.1487591.
   PubMed Web of Science ®Google Scholar
• Guo Y, Li M, Zhang X, et al. The usefulness of three-dimensional ultrasound fusion imaging for precise needle placement in liver thermal ablation: a phantom and an in vivo simulation study. Int J Hyperthermia. 2022;39(1):564–571. doi: 10.1080/02656736.2022.2057596.
   PubMed Web of Science ®Google Scholar
• Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-Event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533–540. doi: 10.1148/radiol.2021203715.
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202. doi: 10.1097/01.rvi.0000094584.83406.3e.
   PubMed Web of Science ®Google Scholar
• You Y, Zhang M, Li K, et al. Feasibility of 3D US/CEUS-US/CEUS fusion imaging-based ablation planning in liver tumors: a retrospective study. Abdom Radiol (NY). 2021;46(6):2865–2874. doi: 10.1007/s00261-020-02909-5.
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang G, Ye J, et al. 3-D contrast-enhanced ultrasound fusion imaging: a new technique to evaluate the ablative margin of radiofrequency ablation for hepatocellular carcinoma. Ultrasound Med Biol. 2019;45(8):1933–1943. doi: 10.1016/j.ultrasmedbio.2019.03.019.
   PubMed Web of Science ®Google Scholar
• Minami Y, Kudo M. Image guidance in ablation for hepatocellular carcinoma: contrast-enhanced ultrasound and fusion imaging. Front Oncol. 2021;11:593636. doi: 10.3389/fonc.2021.593636.
   PubMed Web of Science ®Google Scholar
• Du J, Li HL, Zhai B, et al. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results. Ultrasound Med Biol. 2015;41(9):2400–2411. doi: 10.1016/j.ultrasmedbio.2015.05.004.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang X, Xing L, et al. The application comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in radiofrequency ablation treatment for hepatocellular carcinoma. Cancer Biother Radiopharm. 2019;34(10):621–625. doi: 10.1089/cbr.2019.2845.
   PubMed Web of Science ®Google Scholar
• Ma S, Ding M, Li J, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. J Cancer Res Clin Oncol. 2017;143(1):131–142. doi: 10.1007/s00432-016-2266-5.
   PubMed Web of Science ®Google Scholar
• Clasen S, Rempp H, Hoffmann R, et al. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Eur J Radiol. 2014;83(1):111–116. doi: 10.1016/j.ejrad.2013.09.018.
   PubMed Web of Science ®Google Scholar
• Pusceddu C, Melis L, Ballicu N, et al. Percutaneous microwave ablation under CT guidance for hepatocellular carcinoma: a single institutional experience. J Gastrointest Cancer. 2018;49(3):295–301. doi: 10.1007/s12029-017-9951-8.
   PubMedGoogle Scholar
• Ding WZ, Wei H, Wu JP, et al. Liver cirrhosis and tumor location can affect the range of intrahepatic microwave ablation zone. Int J Hyperthermia. 2023;40(1):2181843. doi: 10.1080/02656736.2023.2181843.
   PubMed Web of Science ®Google Scholar
• Jiang C, Liu B, Chen S, et al. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging. Int J Hyperthermia. 2018;34(8):1135–1141. doi: 10.1080/02656736.2017.1411981.
   PubMed Web of Science ®Google Scholar
• Lee MW, Kang D, Lim HK, et al. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival. Eur Radiol. 2020;30(4):2391–2400. doi: 10.1007/s00330-019-06575-0.
   PubMed Web of Science ®Google Scholar
• Hirooka M, Koizumi Y, Tanaka T, et al. Efficacy of combining electric-field and coronal-plane imaging to obtain ultrasound-ultrasound fusion images in monopolar radiofrequency ablation for patients with liver cancer. Hepatol Res. 2020;50(8):985–995. doi: 10.1111/hepr.13527.
   PubMed Web of Science ®Google Scholar
• Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137(3):850–855. doi: 10.1053/j.gastro.2009.06.003.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70(6):1133–1144. doi: 10.1016/j.jhep.2019.02.023.
   PubMed Web of Science ®Google Scholar
• Wang K, Xiang YJ, Yu HM, et al. A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion. Eur J Surg Oncol. 2022;48(6):1348–1355. doi: 10.1016/j.ejso.2021.12.466.
   PubMed Web of Science ®Google Scholar
• Sheng Y, Sun X, Sun H, et al. Fusion imaging versus ultrasound-guided percutaneous thermal ablation of liver cancer: a meta-analysis. Acta Radiol. 2023;64(9):2506–2517. doi: 10.1177/02841851231187638.
   PubMed Web of Science ®Google Scholar
• Huang Q, Zeng Q, Long Y, et al. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma - A prospective randomized controlled trial. Int J Hyperthermia. 2019;36(1):1207–1215. doi: 10.1080/02656736.2019.1687945.
   PubMed Web of Science ®Google Scholar
• Ju JX, Zeng QJ, Xu EJ, et al. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound. Int J Hyperthermia. 2019;36(1):785–793. doi: 10.1080/02656736.2019.1640899.
   PubMed Web of Science ®Google Scholar
• Liu J, Li L, Zeng Q, et al. Prevention of major biliary complications by fusion imaging for thermal ablation of malignant liver tumors adjacent to the bile ducts: a preliminary comparative study. Abdom Radiol (NY). 2022;47(12):4245–4253. doi: 10.1007/s00261-022-03631-0.
   PubMed Web of Science ®Google Scholar
• You Y, Long Y, Yan R, et al. Improving ablation safety for hepatocellular carcinoma proximal to the hilar bile ducts by ultrasound-MR fusion imaging: a preliminary comparative study. Front Oncol. 2021;11:570312. doi: 10.3389/fonc.2021.570312.
   PubMed Web of Science ®Google Scholar